A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors
Status:
Completed
Trial end date:
2020-02-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of
Niraparib in Japanese participants with advanced solid tumors.